Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Pfizer or Novo if you read this

<< Previous

Bullboard Posts

Next >>

Comment by JayjayUSA12007on Mar 22, 2022 7:44pm

133 Views

Post# 34536180

RE:Pfizer or Novo if you read this

" 5$ will do it for me." ???
You invested in Thera this long to settle for $5/share ???
It's a all or nothing type of deal !
If TH1902 doesn't work, the share price would reflect existing sales of Tesamorelin and Trogarzo.
If TH1902 works, share price will be far far higher than $5/share.
Take your pick....

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property